Cauterization of the Anterior Ethmoidal Artery by Transconjunctival Approach (AEA)
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Léa FATH, MD
- Phone Number: 33 3 88 12 64 98
- Email: lea.fath@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67091
- Recruiting
- Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France
-
Sub-Investigator:
- Idir DJENNAOUI, MD
-
Contact:
- Léa FATH, MD
- Phone Number: 33 3 88 12 64 98
- Email: lea.fath@chru-strasbourg.fr
-
Principal Investigator:
- Léa Fath, MD
-
Principal Investigator:
- Alexandra LEON, MD
-
Sub-Investigator:
- Christian DEBRY, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion criteria:
- Male or female (age ≥18 years)
- Persistent epistaxis after meching
- Having required transconjunctival anterior ethmoidal artery cauterization surgery
- Subject operated at the University Hospitals of Strasbourg between 01/01/2015 and 01/05/2023
- Subject not objecting to the reuse of his/her data for scientific research purposes.
Exclusion Criteria:
- Subject who has expressed opposition to the reuse of his/her data for scientific research purposes.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To retrospectively compare the efficacy of transconjunctival and external cauterization of the anterior ethmoidal artery in patients with refractory epistaxis
Time Frame: Files analysed retrospectively from January 01, 2015 to May 01, 2023 will be examined
|
The endpoint is the efficacy of the technique with the presence of postoperative epistaxis recurrence
|
Files analysed retrospectively from January 01, 2015 to May 01, 2023 will be examined
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 8719
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.